Prot# BAY1747846: Multicenter, Single-Blind, Adaptive Dose Finding Study of Single Intravenous Injections of BAY 1747846 with Corresponding Blinded Read in Adult Participants with Known or Highly Suspected CNS Lesions Referred for Contrast-Enhanced MRI of

Project: Research project

Project Details

StatusFinished
Effective start/end date3/29/19 → 9/29/23

Funding

  • Bayer HealthCare Pharmaceuticals, Inc. (Prot# BAY1747846)